Lairson DR, Parikh RC, Cormier JN, Wenyaw C, Du XL. Cost-utility analysis of treatments for advanced non-small cell lung cancer. Am J Pharm Benefits. 2015 Nov;7(6):271-9.
Lopes M, Chulikavit M, Parikh R, Stern L, Liu Z, Rogerio J. Budget impact of everolimus in treating metastatic renal cell carcinoma. Am J Pharm Benefits. 2012;4(Special Issue):sp41-8.
Scotland GS, Philip S, Fleming AD, Goatman KA, Sharp PF, McNamee P, Fonseca S, Prescott G, Olson JA. Manual versus automated: the diabetic retinopathy screening debate. OTE. 2008 Jan 1;4(2):14-6.